Anti‐early endosome antigen 1 autoantibodies were detected in a pemphigus‐like patient but not in the majority of pemphigus diseases
-
- Ryuhei Nishikawa
- Department of Dermatology Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology Kurume Fukuoka Japan
-
- Hitoshi Takahashi
- Department of Dermatology Shimane University Faculty of Medicine Izumo Shimane Japan
-
- Mitsuhiro Matsuda
- Department of Dermatology Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology Kurume Fukuoka Japan
-
- Kaoru Imaoka
- Department of Dermatology Shimane University Faculty of Medicine Izumo Shimane Japan
-
- Masahiro Ogawa
- Department of Dermatology Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology Kurume Fukuoka Japan
-
- Kwesi Teye
- Department of Dermatology Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology Kurume Fukuoka Japan
-
- Atsunari Tsuchisaka
- Department of Dermatology Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology Kurume Fukuoka Japan
-
- Hiroshi Koga
- Department of Dermatology Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology Kurume Fukuoka Japan
-
- Lars Komorowski
- Institute for Experimental Immunology Affiliated to Euroimmun AG Luebeck Germany
-
- Christian Probst
- Institute for Experimental Immunology Affiliated to Euroimmun AG Luebeck Germany
-
- Takahisa Hachiya
- Antibody Engineering Department/Manufacturing Division Medical & Biological Laboratories Co., Ltd. Nagoya Japan
-
- Marvin J. Fritzler
- Cumming School of Medicine University of Calgary Calgary Canada
-
- Norito Ishii
- Department of Dermatology Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology Kurume Fukuoka Japan
-
- Chika Ohata
- Department of Dermatology Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology Kurume Fukuoka Japan
-
- Minao Furumura
- Department of Dermatology Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology Kurume Fukuoka Japan
-
- Rafal P. Krol
- Department of Dermatology Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology Kurume Fukuoka Japan
-
- Yoshinao Muro
- Division of Connective Tissue Disease and Autoimmunity Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Japan
-
- Eishin Morita
- Department of Dermatology Shimane University Faculty of Medicine Izumo Shimane Japan
-
- Takashi Hashimoto
- Department of Dermatology Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology Kurume Fukuoka Japan
この論文をさがす
説明
<jats:title>Abstract</jats:title><jats:p>Although the major autoantigens in classic pemphigus are desmogleins, sera from various types of pemphigus react with a number of other molecules, including desmocollins and plakin proteins. However, other novel pemphigus‐related autoantigens remain to be identified. In this study, <jats:bold>i</jats:bold>mmunoblotting for serum from an atypical autoimmune bullous disease patient identified an unknown 175 <jats:styled-content style="fixed-case">kD</jats:styled-content>a protein. Subsequent studies using two‐dimensional gel electrophoresis, immunoblotting and mass‐spectrometry identified the 175 kDa protein as early endosome antigen 1 (<jats:styled-content style="fixed-case">EEA</jats:styled-content>1). This finding was confirmed by subsequent immunological studies, including indirect immunofluorescence of skin and cultured keratinocytes, two‐dimensional gel electrophoresis and immunoblotting with anti‐<jats:styled-content style="fixed-case">EEA</jats:styled-content>1 polyclonal antibody, and preabsorption with <jats:styled-content style="fixed-case">EEA</jats:styled-content>1 recombinant protein. Finally, we developed a novel <jats:styled-content style="fixed-case">BIOCHIP</jats:styled-content> assay using full‐length <jats:styled-content style="fixed-case">EEA</jats:styled-content>1 recombinant protein to detect anti‐<jats:styled-content style="fixed-case">EEA</jats:styled-content>1 antibodies. However, none of 35 sera from various types of pemphigus showed anti‐<jats:styled-content style="fixed-case">EEA</jats:styled-content>1 antibodies in the <jats:styled-content style="fixed-case">BIOCHIP</jats:styled-content> assay, with the exception of the serum from the index case. In addition, various findings in the index case did not suggest pathogenic role of anti‐<jats:styled-content style="fixed-case">EEA</jats:styled-content>1 autoantibodies. Therefore, although we successfully identified the 175 <jats:styled-content style="fixed-case">kD</jats:styled-content>a protein reacted by a serum of an atypical pemphigus‐like patient as <jats:styled-content style="fixed-case">EEA</jats:styled-content>1, novel <jats:styled-content style="fixed-case">BIOCHIP</jats:styled-content> study for other pemphigus sera indicated that <jats:styled-content style="fixed-case">EEA</jats:styled-content>1 is not a common and pathogenic autoantigen in pemphigus.</jats:p>
収録刊行物
-
- Experimental Dermatology
-
Experimental Dermatology 25 (5), 368-374, 2016-05
Wiley